Pittelkow MR - Search Results

1

Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment.

Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET; Melanoma Study Group of Mayo Clinic Cancer Center. Markovic SN, et al. Among authors: pittelkow mr. Mayo Clin Proc. 2007 Apr;82(4):490-513. doi: 10.4065/82.4.490. Mayo Clin Proc. 2007. PMID: 17418079 Review.

2

Tissue plasminogen activator for treatment of livedoid vasculitis.

Klein KL, Pittelkow MR. Klein KL, et al. Among authors: pittelkow mr. Mayo Clin Proc. 1992 Oct;67(10):923-33. doi: 10.1016/s0025-6196(12)60922-7. Mayo Clin Proc. 1992. PMID: 1434852 Clinical Trial.

3

Cyclosporine in the treatment of dermatologic disease: an update.

Lim KK, Su WP, Schroeter AL, Sabers CJ, Abraham RT, Pittelkow MR. Lim KK, et al. Among authors: pittelkow mr. Mayo Clin Proc. 1996 Dec;71(12):1182-91. doi: 10.4065/71.12.1182. Mayo Clin Proc. 1996. PMID: 8945493 Review.

4

Extracorporeal photopheresis and adjuvant aerosolized granulocyte-macrophage colony-stimulating factor for Sézary syndrome.

Bouwhuis SA, Markovic SN, McEvoy MT, Pittelkow MR. Bouwhuis SA, et al. Among authors: pittelkow mr. Mayo Clin Proc. 2002 Feb;77(2):197-200. doi: 10.4065/77.2.197. Mayo Clin Proc. 2002. PMID: 11838656

5

High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.

Mehrany K, Weenig RH, Pittelkow MR, Roenigk RK, Otley CC. Mehrany K, et al. Among authors: pittelkow mr. Arch Dermatol. 2004 Aug;140(8):985-8. doi: 10.1001/archderm.140.8.985. Arch Dermatol. 2004. PMID: 15313816

6

Malignant basomelanocytic tumor manifesting as metastatic melanoma.

Erickson LA, Myers JL, Mihm MC, Markovic SN, Pittelkow MR. Erickson LA, et al. Among authors: pittelkow mr. Am J Surg Pathol. 2004 Oct;28(10):1393-6. doi: 10.1097/01.pas.0000135526.19189.31. Am J Surg Pathol. 2004. PMID: 15371958

7

Low-dose tissue plasminogen activator for calciphylaxis.

Sewell LD, Weenig RH, Davis MD, McEvoy MT, Pittelkow MR. Sewell LD, et al. Among authors: pittelkow mr. Arch Dermatol. 2004 Sep;140(9):1045-8. doi: 10.1001/archderm.140.9.1045. Arch Dermatol. 2004. PMID: 15381542 No abstract available.

8

Effectiveness of intravenous immunoglobulin therapy for skin disease other than toxic epidermal necrolysis: a retrospective review of Mayo Clinic experience.

Wetter DA, Davis MD, Yiannias JA, Gibson LE, Dahl MV, el-Azhary RA, Bruce AJ, Lookingbill DP, Ahmed I, Schroeter AL, Pittelkow MR. Wetter DA, et al. Among authors: pittelkow mr. Mayo Clin Proc. 2005 Jan;80(1):41-7. doi: 10.1016/S0025-6196(11)62956-X. Mayo Clin Proc. 2005. PMID: 15667028

9

High recurrence rates of squamous cell carcinoma after Mohs' surgery in patients with chronic lymphocytic leukemia.

Mehrany K, Weenig RH, Pittelkow MR, Roenigk RK, Otley CC. Mehrany K, et al. Among authors: pittelkow mr. Dermatol Surg. 2005 Jan;31(1):38-42; discussion 42. doi: 10.1111/j.1524-4725.2005.31006. Dermatol Surg. 2005. PMID: 15720094

10

Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia.

Mehrany K, Weenig RH, Lee KK, Pittelkow MR, Otley CC. Mehrany K, et al. Among authors: pittelkow mr. J Am Acad Dermatol. 2005 Dec;53(6):1067-71. doi: 10.1016/j.jaad.2005.08.055. J Am Acad Dermatol. 2005. PMID: 16310071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

387 results

Search Page